Technical Analysis for MRNA - Moderna, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 149.71 | 7.40% | 10.31 |
MRNA closed up 7.4 percent on Tuesday, April 13, 2021, on 1.47 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
Earnings due: May 5
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Historical MRNA trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 50 DMA | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Stochastic Reached Overbought | Strength | 0.00% | |
| Multiple of Ten Bearish | Other | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 7.40% | |
| 20 DMA Support | Bullish | 7.40% | |
| Multiple of Ten Bearish | Other | 7.40% | |
| Inside Day | Range Contraction | 7.40% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Trending on StockTwits | about 2 hours ago |
| Possible Pocket Pivot | about 8 hours ago |
| 50 DMA Resistance | about 10 hours ago |
| Rose Above 50 DMA | about 12 hours ago |
| 3x Volume Pace | about 12 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/05/2021
Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Life Sciences Biology Coronavirus Vaccine Cancer Vaccine RNA Cancer Vaccines Messenger RNA
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Life Sciences Biology Coronavirus Vaccine Cancer Vaccine RNA Cancer Vaccines Messenger RNA
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 189.26 |
| 52 Week Low | 36.62 |
| Average Volume | 9,057,374 |
| 200-Day Moving Average | 105.25 |
| 50-Day Moving Average | 148.78 |
| 20-Day Moving Average | 136.67 |
| 10-Day Moving Average | 134.08 |
| Average True Range | 9.01 |
| ADX | 14.24 |
| +DI | 30.96 |
| -DI | 18.66 |
| Chandelier Exit (Long, 3 ATRs ) | 130.71 |
| Chandelier Exit (Short, 3 ATRs ) | 144.37 |
| Upper Bollinger Band | 154.19 |
| Lower Bollinger Band | 119.14 |
| Percent B (%b) | 0.87 |
| BandWidth | 25.64 |
| MACD Line | -1.13 |
| MACD Signal Line | -3.42 |
| MACD Histogram | 2.2919 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 159.85 | ||||
| Resistance 3 (R3) | 159.52 | 155.82 | 158.16 | ||
| Resistance 2 (R2) | 155.82 | 153.23 | 155.98 | 157.60 | |
| Resistance 1 (R1) | 152.76 | 151.64 | 154.29 | 153.09 | 157.03 |
| Pivot Point | 149.06 | 149.06 | 149.82 | 149.22 | 149.06 |
| Support 1 (S1) | 146.00 | 146.47 | 147.53 | 146.33 | 142.39 |
| Support 2 (S2) | 142.30 | 144.88 | 142.46 | 141.82 | |
| Support 3 (S3) | 139.24 | 142.30 | 141.26 | ||
| Support 4 (S4) | 139.57 |
